PubMed:15821891
Annnotations
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 15821891-2#200#216#gene64006 | 464-480 | gene64006 | denotes | envelope protein |
| 15821891-2#200#216#gene30816 | 464-480 | gene30816 | denotes | envelope protein |
| 15821891-2#174#178#gene7433 | 438-442 | gene7433 | denotes | HVR1 |
| 15821891-2#196#199#diseaseC0019196 | 460-463 | diseaseC0019196 | denotes | HCV |
| 15821891-2#196#199#diseaseC0019196 | 460-463 | diseaseC0019196 | denotes | HCV |
| 15821891-4#228#231#gene309 | 822-825 | gene309 | denotes | p70 |
| 15821891-4#228#231#gene84959 | 822-825 | gene84959 | denotes | p70 |
| 15821891-4#236#241#gene3600 | 830-835 | gene3600 | denotes | IL-15 |
| 15821891-4#38#41#diseaseC0019196 | 632-635 | diseaseC0019196 | denotes | HCV |
| 15821891-4#38#41#diseaseC0019196 | 632-635 | diseaseC0019196 | denotes | HCV |
| 200#216#gene64006196#199#diseaseC0019196 | 15821891-2#200#216#gene64006 | 15821891-2#196#199#diseaseC0019196 | associated_with | envelope protein,HCV |
| 200#216#gene64006196#199#diseaseC0019196 | 15821891-2#200#216#gene64006 | 15821891-2#196#199#diseaseC0019196 | associated_with | envelope protein,HCV |
| 200#216#gene30816196#199#diseaseC0019196 | 15821891-2#200#216#gene30816 | 15821891-2#196#199#diseaseC0019196 | associated_with | envelope protein,HCV |
| 200#216#gene30816196#199#diseaseC0019196 | 15821891-2#200#216#gene30816 | 15821891-2#196#199#diseaseC0019196 | associated_with | envelope protein,HCV |
| 174#178#gene7433196#199#diseaseC0019196 | 15821891-2#174#178#gene7433 | 15821891-2#196#199#diseaseC0019196 | associated_with | HVR1,HCV |
| 174#178#gene7433196#199#diseaseC0019196 | 15821891-2#174#178#gene7433 | 15821891-2#196#199#diseaseC0019196 | associated_with | HVR1,HCV |
| 228#231#gene30938#41#diseaseC0019196 | 15821891-4#228#231#gene309 | 15821891-4#38#41#diseaseC0019196 | associated_with | p70,HCV |
| 228#231#gene30938#41#diseaseC0019196 | 15821891-4#228#231#gene309 | 15821891-4#38#41#diseaseC0019196 | associated_with | p70,HCV |
| 228#231#gene8495938#41#diseaseC0019196 | 15821891-4#228#231#gene84959 | 15821891-4#38#41#diseaseC0019196 | associated_with | p70,HCV |
| 228#231#gene8495938#41#diseaseC0019196 | 15821891-4#228#231#gene84959 | 15821891-4#38#41#diseaseC0019196 | associated_with | p70,HCV |
| 236#241#gene360038#41#diseaseC0019196 | 15821891-4#236#241#gene3600 | 15821891-4#38#41#diseaseC0019196 | associated_with | IL-15,HCV |
| 236#241#gene360038#41#diseaseC0019196 | 15821891-4#236#241#gene3600 | 15821891-4#38#41#diseaseC0019196 | associated_with | IL-15,HCV |
DisGeNet-2017-sample
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1789 | 464-480 | gene:64006 | denotes | envelope protein |
| T1790 | 460-463 | disease:C0019196 | denotes | HCV |
| T1791 | 822-825 | gene:309 | denotes | p70 |
| T1792 | 632-635 | disease:C0019196 | denotes | HCV |
| R1 | T1789 | T1790 | associated_with | envelope protein,HCV |
| R2 | T1789 | T1790 | associated_with | envelope protein,HCV |
| R3 | T1791 | T1792 | associated_with | p70,HCV |
| R4 | T1791 | T1792 | associated_with | p70,HCV |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-136 | Sentence | denotes | Immunogenic properties of a chimeric plant virus expressing a hepatitis C virus (HCV)-derived epitope: new prospects for an HCV vaccine. |
| TextSentencer_T2 | 137-263 | Sentence | denotes | A vaccine against Hepatitis C virus (HCV) is urgently needed due to the unsatisfactory clinical response to current therapies. |
| TextSentencer_T3 | 264-498 | Sentence | denotes | We evaluated the immunological properties of a chimeric Cucumber mosaic virus (CMV), a plant virus engineered to express on its surface a synthetic peptide derived from many HVR1 sequences of the HCV envelope protein E2 (R9 mimotope). |
| TextSentencer_T4 | 499-593 | Sentence | denotes | Evidence was obtained that the chimeric R9-CMV elicits a specific humoral response in rabbits. |
| TextSentencer_T5 | 594-863 | Sentence | denotes | Furthermore, in patients with chronic HCV infection, purified preparations of R9-CMV down-modulated the lymphocyte surface density of CD3 and CD8, and induced a significant release of interferon (IFN)-gamma, interleukin (IL)-12 p70 and IL-15 by lymphomonocyte cultures. |
| TextSentencer_T6 | 864-1022 | Sentence | denotes | Finally, an R9 mimotope-specific CD8 T-cell response, as assessed by intracellular IFN-gamma production, was achieved in the majority of the patients studied. |
| TextSentencer_T7 | 1023-1121 | Sentence | denotes | Our results open up new prospects for the development of effective vaccines against HCV infection. |
| TextSentencer_T8 | 1122-1220 | Sentence | denotes | Moreover, the wide edible host range of CMV makes the production of an edible vaccine conceivable. |
| T1 | 0-136 | Sentence | denotes | Immunogenic properties of a chimeric plant virus expressing a hepatitis C virus (HCV)-derived epitope: new prospects for an HCV vaccine. |
| T2 | 137-263 | Sentence | denotes | A vaccine against Hepatitis C virus (HCV) is urgently needed due to the unsatisfactory clinical response to current therapies. |
| T3 | 264-498 | Sentence | denotes | We evaluated the immunological properties of a chimeric Cucumber mosaic virus (CMV), a plant virus engineered to express on its surface a synthetic peptide derived from many HVR1 sequences of the HCV envelope protein E2 (R9 mimotope). |
| T4 | 499-593 | Sentence | denotes | Evidence was obtained that the chimeric R9-CMV elicits a specific humoral response in rabbits. |
| T5 | 594-863 | Sentence | denotes | Furthermore, in patients with chronic HCV infection, purified preparations of R9-CMV down-modulated the lymphocyte surface density of CD3 and CD8, and induced a significant release of interferon (IFN)-gamma, interleukin (IL)-12 p70 and IL-15 by lymphomonocyte cultures. |
| T6 | 864-1022 | Sentence | denotes | Finally, an R9 mimotope-specific CD8 T-cell response, as assessed by intracellular IFN-gamma production, was achieved in the majority of the patients studied. |
| T7 | 1023-1121 | Sentence | denotes | Our results open up new prospects for the development of effective vaccines against HCV infection. |
| T8 | 1122-1220 | Sentence | denotes | Moreover, the wide edible host range of CMV makes the production of an edible vaccine conceivable. |